Clinical Trial Update: Study of ExAblate Focused Ultrasound Ablation of Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating ExAblate focused ultrasound ablation for breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Exablate Focused Ultrasound

Snippet

Sponsor: InSightec | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED